This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Germany
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrugA study involving a medication or substance.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Germany
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrug
Countries
Germany
Sponsor
Pfizer Inc, 235 East 42nd Street, New York, NY 10017, US
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Germany
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrug
Countries
Germany
Sponsor
Medical Institutions of the District Oberpfalz/Bayern (MedBO GmbH)
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Italy
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrug
Countries
Italy
Sponsor
AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In United Kingdom
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrug
Countries
United Kingdom
Sponsor
Kings College London [...] 1. Kings College London 2. South London and Maudsley NHS Foundation Trust
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Austria
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrug
Countries
Austria, Germany, Hungary, ...
Sponsor
Institut de Recherches Internationales Servier [...] 1. Institut de Recherches Internationales Servier 2. Laboratorios Servier S.L. (For Spain only) 3. SERVIER Research and Development ICTR (For United Kingdom only)
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Spain
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrug
Countries
Spain
Sponsor
Fundación para la Investigación biomedica del Hospital Gregorio Marañon
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.
